Diabetic Foot Ulcer Market Size, Growth | Report by 2028

report image

Diabetic Foot Ulcer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)

Publication Month: May 2021 | Report Code: TIPRE00022321 | No. of Pages: 240 | Category: Pharmaceuticals | Status: Published

The diabetic foot ulcer market is expected to reach US$ 7,793.83 million by 2028 from US$ 4,279.65 million in 2020; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028.

Diabetic foot ulcer is a frequent complication in diabetic patients, and it may lead to leg amputation. Diabetes patients, who rely on insulin as a part of diabetes therapy, are at a higher risk of developing a foot ulcer. Diabetic foot ulcers can also affect patients who have diabetes-related kidney, skin, or heart disease, as well as obesity. Also, people who consume alcohol have a higher risk of developing the diabetic foot ulcer. The growth of the diabetic foot ulcer market is attributed to the factors such as the increasing prevalence of diabetes and related chronic wounds and rising geriatric population. However, the high cost of advanced wound care treatments hinders the market growth.  

Lucrative Regions for Diabetic Foot Ulcer Market


Lucrative Regions for Diabetic Foot Ulcer Market

Get more information on this report :



Market Insights

Increasing Prevalence of Diabetes and Related Chronic Wounds

Depending on time taken to heal, wounds can be classified as acute and chronic. Diabetes has emerged as one of the most impactful health emergencies of the world in the 21st century. As per the National Diabetes Statistics Report 2020, ~34.2 million people in the US have diabetes, and the diabetic population accounts for ~10.5% of the overall US population. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was ~46 million in 2017, and it is expected to reach 62 million by 2045, with the disease prevalence of ~35% during 2018–2045. Diabetes affects many parts of the body, particularly the feet. Diabetic foot ulcers are sores developed on feet; they can also develop from seemingly trivial injuries to the feet. Diabetic foot ulcers are the common causes of amputation due to diabetes. According to a report published in the International Journal of Endocrinology in 2017, 15–25% of patients with diabetes are susceptible to foot ulcers during their lifetime. The risk of developing diabetic foot ulcers in patients diagnosed with diabetes is anticipated to be 2%; however, in patients with a previous history of foot ulceration, this risk is expected to increase to 17–60% over the next three years. ~20% of hospital admissions in people with diabetes are because of foot ulcers.

As there are continuous occurrences of injuries caused due to diabetes in low- and medium-income, and high-income countries, the demand for diabetic foot ulcer treatments is on rise.

Type-Based Insights

By type, the diabetic foot ulcer market is segmented into advanced wound care dressings, biologics, and therapy device. In 2020, the advanced wound care dressings segment held the largest share of the market. However, the biologics segment is estimated to register the highest CAGR during the forecast period owing to the factors such as growing research and development activities and surging new products launches for diabetic foot ulcer treatment.

Diabetic Foot Ulcer Market, by Products – 2020 and 2028



Diabetic Foot Ulcer Market, by Products – 2020 and 2028

Get more information on this report :

Ulcer Type-Based Insights

The diabetic foot ulcer treatment market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. In 2020, the neuropathic ulcers segment held the largest share of the market, and the market for the same segment is expected to grow at the fastest rate in the coming years.

End User-based Insights

Based on end user, the diabetic foot ulcer treatment market is segmented into ambulatory surgical centers, hospitals, and home care. In 2020, the hospitals segment held the largest share of the market. Also, the market for the same segment is expected to grow at the fastest rate in the coming years owing to the availability of diabetologist, plastic surgeon, and other respective professionals in hospitals who take care of diabetic foot patients.


Strategic Insights

Report Coverage - Diabetic Foot Ulcer Market
Report CoverageDetails
Market Size Value inUS$ 4,279.65 Million in 2020
Market Size Value byUS$ 7,793.83 Million by 2028
Growth rateCAGR of 7.9% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages240
No. of Tables165
No. of Charts & Figures83
Historical data availableYes
Segments coveredType , Ulcer Type , and End User
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the diabetic foot ulcer market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

Diabetic Foot Ulcer Market – by Type

  • Advanced Wound Care Dressings
  • Biologics
  • Therapy Device

Diabetic Foot Ulcer Market – by Ulcer Type

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers

Diabetic Foot Ulcer Market – by End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care

Diabetic Foot Ulcer Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • ConvaTec Group Plc         
  • 3M         
  • Coloplast Group           
  • Smith & Nephew          
  • B. Braun Melsungen AG          
  • Medline Industries, Inc.           
  • Cardinal Health Inc       
  • Organogenesis Inc.      
  • Mölnlycke Health Care AB.       
  • MiMedx            
  • URGO     
  • Kerecis

Frequently Asked Questions

Diabetic foot ulcers are a frequent complication in diabetic patients, and they may lead to leg amputation. Diabetes patients who rely on insulin for therapy are at a higher risk of developing a foot ulcer. Diabetic foot ulcers can also affect patients who have diabetes-related kidney, skin, or heart disease, as well as others who are obese. Those that use alcohol have a higher risk of developing the condition.
The global diabetic foot ulcer market growth is mainly attributed to factors such increasing prevalence of diabetes and related chronic wounds and rise in the geriatric population. However, the high cost of advanced wound care treatments is a key factor restraining the market growth.
The diabetic foot ulcer market majorly consists of the players such as ConvaTec Inc; 3M Company (Acelity L.P. Inc.); Coloplast A/S; Smith & Nephew plc; B. Braun Melsungen AG; Medline Industries, Inc; Cardinal Health Inc; Organogenesis Holdings Inc; Mölnlycke Health Care; MiMedx Group, Inc; Kerecis hf, and URGO among others.

The List of Companies - Diabetic Foot Ulcer Treatment Market

  1. ConvaTec Group Plc
  2. 3M
  3. Coloplast Group               
  4. Smith & Nephew               
  5. B. Braun Melsungen AG    
  6. Medline Industries, Inc.     
  7. Cardinal Health Inc            
  8. Organogenesis Inc.          
  9. Mölnlycke Health Care AB.            
  10. MiMedx    
  11. URGO      
  12. Kerecis
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the diabetic foot ulcer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global diabetic foot ulcer market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00022321
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount